ABN Amro: UBS raises target price
(CercleFinance.com) - UBS maintains its "buy" rating on ABN Amro shares, increasing its target price for them from E20 to E20.
7, with the new target representing 50% upside potential for the Dutch bank's share.
"ABN has reported solid Q1 numbers and we expect material consensus EPS upgrades," the broker said, raising its own projections for the group to double-digit percentages.
According to the broker, for whom there is significant upside potential in the stock, " Key focus is likely to be on net interest income trajectory and capital return," following the better-than-expected quarterly results.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
7, with the new target representing 50% upside potential for the Dutch bank's share.
"ABN has reported solid Q1 numbers and we expect material consensus EPS upgrades," the broker said, raising its own projections for the group to double-digit percentages.
According to the broker, for whom there is significant upside potential in the stock, " Key focus is likely to be on net interest income trajectory and capital return," following the better-than-expected quarterly results.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.